Translational Development Acquisition Corp. Agrees $50M Subscription for Merger

What Happened
Translational Development Acquisition Corp. (TDAC) filed an 8-K on July 27, 2026 disclosing a Subscription Agreement with Naetas Holding Limited (the Subscriber) to purchase 5,000,000 Class A TDAC shares at $10.00 each for $50,000,000 in connection with TDAC’s previously announced merger with ProLogium Holding Inc. The subscription also contemplates issuing up to 5,000,000 warrants (one per subscribed share) on substantially the same terms as TDAC’s public warrants. The Subscription Closing is expected one business day prior to the first merger closing; funds will be placed in escrow and will be returned if the Business Combination does not close.

Key Details

• Subscriber: Naetas Holding Limited agreed to buy 5,000,000 TDAC Class A shares for $50,000,000 (price = $10.00/share).
• Warrants: Up to 5,000,000 Subscribed Warrants to be issued (one per share); exercise price $11.50, redemption trigger $18.00, redemption price $0.01; no downward reset or ratchet protections other than customary anti-dilution.
• Conversion on closing: At the effective time of the first merger each Subscribed Share will be cancelled for the right to one ProLogium Class A share; each Subscribed Warrant unexercised will convert into one ProLogium warrant.
• Conditions & timing: Closing is subject to customary closing conditions and the Business Combination closing schedule; Purchase Price is funded to escrow and returned if the Business Combination is not consummated.
• Registration efforts: ProLogium agreed to use commercially reasonable efforts to file and cause effective a resale registration statement for the securities received in exchange for the Subscribed Securities (file within 45 days after closing; effective within 90/120 days subject to SEC review timelines).
• Deal protections: TDAC and ProLogium generally agreed not to enter a more favorable PIPE before the Subscription Closing without offering the Subscriber matching terms.

Why It Matters
This subscription provides a committed $50M PIPE commitment supporting TDAC’s pending business combination with ProLogium, which can reduce financing risk and help ensure the merger closes as planned. Investors should note potential dilution from the new shares and warrants and that the warrants carry an $11.50 exercise price and limited holder protections. The securities are being issued in a private placement (unregistered sale) and are expected to convert into ProLogium securities at closing; ProLogium has agreed to seek registration to enable resale, but resale liquidity depends on timely SEC effectiveness and other conditions.